Global Biothrax (Anthrax Vaccine) Market Insights, Forecast to 2034
Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax. Biothrax, commonly known as the anthrax vaccine, is a medical countermeasure developed to protect individuals from anthrax, a potentially lethal bacterial infection caused by Bacillus anthracis. The vaccine is used primarily for military personnel, laboratory workers, and individuals at high risk of exposure to anthrax spores. It stimulates the immune system to produce antibodies against the anthrax toxin, preventing the progression of the disease if exposed to the bacteria. Biothrax is administered through a series of doses and boosters and is a critical component of preparedness against bioterrorism threats involving anthrax.
Global Biothrax (Anthrax Vaccine) market is expected to reach to US$ 679.9 million in 2024, with a positive growth of %, compared with US$ 655 million in 2022. Backed with the increasing demand from downstream industries, Biothrax (Anthrax Vaccine) industry is evaluated to reach US$ 1059.2 million in 2029. The CAGR will be 7.7% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Biothrax (Anthrax Vaccine) market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Biothrax (Anthrax Vaccine) market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Merial
Merck
Zoetis
Bayer Sanidad Animal
Colorado Serum
PharmAthene
Tiankang
Biogénesis-Bago
CAVAC
Rosenbusch
Agrovet
Vecol
CVCRI
IVPM
Prondil
CDV
Indian Immunologicals
Botswana Vaccine Institute
Ceva Santé Animale
Intervac
JOVAC
Segment by Type
Live Vaccines
Cell Free PA Vaccines
Segment by Application
Human Use
Animal Use
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Biothrax (Anthrax Vaccine) plant distribution, commercial date of Biothrax (Anthrax Vaccine), product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Biothrax (Anthrax Vaccine) introduction, etc. Biothrax (Anthrax Vaccine) Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Biothrax (Anthrax Vaccine)
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports
Table of Content
1 Study Coverage
1.1 Biothrax (Anthrax Vaccine) Product Introduction
1.2 Market by Type
1.2.1 Global Biothrax (Anthrax Vaccine) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Live Vaccines
1.2.3 Cell Free PA Vaccines
1.3 Market by Application
1.3.1 Global Biothrax (Anthrax Vaccine) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Human Use
1.3.3 Animal Use
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Biothrax (Anthrax Vaccine) Sales Estimates and Forecasts 2018-2029
2.2 Global Biothrax (Anthrax Vaccine) Revenue by Region
2.2.1 Global Biothrax (Anthrax Vaccine) Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Biothrax (Anthrax Vaccine) Revenue by Region (2018-2024)
2.2.3 Global Biothrax (Anthrax Vaccine) Revenue by Region (2024-2029)
2.2.4 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2018-2029)
2.3 Global Biothrax (Anthrax Vaccine) Sales Estimates and Forecasts 2018-2029
2.4 Global Biothrax (Anthrax Vaccine) Sales by Region
2.4.1 Global Biothrax (Anthrax Vaccine) Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Biothrax (Anthrax Vaccine) Sales by Region (2018-2024)
2.4.3 Global Biothrax (Anthrax Vaccine) Sales by Region (2024-2029)
2.4.4 Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Biothrax (Anthrax Vaccine) Sales by Manufacturers
3.1.1 Global Biothrax (Anthrax Vaccine) Sales by Manufacturers (2018-2024)
3.1.2 Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biothrax (Anthrax Vaccine) in 2022
3.2 Global Biothrax (Anthrax Vaccine) Revenue by Manufacturers
3.2.1 Global Biothrax (Anthrax Vaccine) Revenue by Manufacturers (2018-2024)
3.2.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Biothrax (Anthrax Vaccine) Revenue in 2022
3.3 Global Key Players of Biothrax (Anthrax Vaccine), Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Biothrax (Anthrax Vaccine) Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Biothrax (Anthrax Vaccine), Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Biothrax (Anthrax Vaccine), Product Offered and Application
3.8 Global Key Manufacturers of Biothrax (Anthrax Vaccine), Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Biothrax (Anthrax Vaccine) Sales by Type
4.1.1 Global Biothrax (Anthrax Vaccine) Historical Sales by Type (2018-2024)
4.1.2 Global Biothrax (Anthrax Vaccine) Forecasted Sales by Type (2024-2029)
4.1.3 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2029)
4.2 Global Biothrax (Anthrax Vaccine) Revenue by Type
4.2.1 Global Biothrax (Anthrax Vaccine) Historical Revenue by Type (2018-2024)
4.2.2 Global Biothrax (Anthrax Vaccine) Forecasted Revenue by Type (2024-2029)
4.2.3 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2018-2029)
4.3 Global Biothrax (Anthrax Vaccine) Price by Type
4.3.1 Global Biothrax (Anthrax Vaccine) Price by Type (2018-2024)
4.3.2 Global Biothrax (Anthrax Vaccine) Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Biothrax (Anthrax Vaccine) Sales by Application
5.1.1 Global Biothrax (Anthrax Vaccine) Historical Sales by Application (2018-2024)
5.1.2 Global Biothrax (Anthrax Vaccine) Forecasted Sales by Application (2024-2029)
5.1.3 Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2029)
5.2 Global Biothrax (Anthrax Vaccine) Revenue by Application
5.2.1 Global Biothrax (Anthrax Vaccine) Historical Revenue by Application (2018-2024)
5.2.2 Global Biothrax (Anthrax Vaccine) Forecasted Revenue by Application (2024-2029)
5.2.3 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2018-2029)
5.3 Global Biothrax (Anthrax Vaccine) Price by Application
5.3.1 Global Biothrax (Anthrax Vaccine) Price by Application (2018-2024)
5.3.2 Global Biothrax (Anthrax Vaccine) Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Biothrax (Anthrax Vaccine) Market Size by Type
6.1.1 US & Canada Biothrax (Anthrax Vaccine) Sales by Type (2018-2029)
6.1.2 US & Canada Biothrax (Anthrax Vaccine) Revenue by Type (2018-2029)
6.2 US & Canada Biothrax (Anthrax Vaccine) Market Size by Application
6.2.1 US & Canada Biothrax (Anthrax Vaccine) Sales by Application (2018-2029)
6.2.2 US & Canada Biothrax (Anthrax Vaccine) Revenue by Application (2018-2029)
6.3 US & Canada Biothrax (Anthrax Vaccine) Market Size by Country
6.3.1 US & Canada Biothrax (Anthrax Vaccine) Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Biothrax (Anthrax Vaccine) Sales by Country (2018-2029)
6.3.3 US & Canada Biothrax (Anthrax Vaccine) Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Biothrax (Anthrax Vaccine) Market Size by Type
7.1.1 Europe Biothrax (Anthrax Vaccine) Sales by Type (2018-2029)
7.1.2 Europe Biothrax (Anthrax Vaccine) Revenue by Type (2018-2029)
7.2 Europe Biothrax (Anthrax Vaccine) Market Size by Application
7.2.1 Europe Biothrax (Anthrax Vaccine) Sales by Application (2018-2029)
7.2.2 Europe Biothrax (Anthrax Vaccine) Revenue by Application (2018-2029)
7.3 Europe Biothrax (Anthrax Vaccine) Market Size by Country
7.3.1 Europe Biothrax (Anthrax Vaccine) Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Biothrax (Anthrax Vaccine) Sales by Country (2018-2029)
7.3.3 Europe Biothrax (Anthrax Vaccine) Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Biothrax (Anthrax Vaccine) Market Size
8.1.1 China Biothrax (Anthrax Vaccine) Sales (2018-2029)
8.1.2 China Biothrax (Anthrax Vaccine) Revenue (2018-2029)
8.2 China Biothrax (Anthrax Vaccine) Market Size by Application
8.2.1 China Biothrax (Anthrax Vaccine) Sales by Application (2018-2029)
8.2.2 China Biothrax (Anthrax Vaccine) Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Biothrax (Anthrax Vaccine) Market Size by Type
9.1.1 Asia Biothrax (Anthrax Vaccine) Sales by Type (2018-2029)
9.1.2 Asia Biothrax (Anthrax Vaccine) Revenue by Type (2018-2029)
9.2 Asia Biothrax (Anthrax Vaccine) Market Size by Application
9.2.1 Asia Biothrax (Anthrax Vaccine) Sales by Application (2018-2029)
9.2.2 Asia Biothrax (Anthrax Vaccine) Revenue by Application (2018-2029)
9.3 Asia Biothrax (Anthrax Vaccine) Sales by Region
9.3.1 Asia Biothrax (Anthrax Vaccine) Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Biothrax (Anthrax Vaccine) Revenue by Region (2018-2029)
9.3.3 Asia Biothrax (Anthrax Vaccine) Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Market Size by Type
10.1.1 Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Market Size by Application
10.2.1 Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales by Country
10.3.1 Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Merial
11.1.1 Merial Company Information
11.1.2 Merial Overview
11.1.3 Merial Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Merial Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Merial Recent Developments
11.2 Merck
11.2.1 Merck Company Information
11.2.2 Merck Overview
11.2.3 Merck Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Merck Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Merck Recent Developments
11.3 Zoetis
11.3.1 Zoetis Company Information
11.3.2 Zoetis Overview
11.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Zoetis Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Zoetis Recent Developments
11.4 Bayer Sanidad Animal
11.4.1 Bayer Sanidad Animal Company Information
11.4.2 Bayer Sanidad Animal Overview
11.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Bayer Sanidad Animal Recent Developments
11.5 Colorado Serum
11.5.1 Colorado Serum Company Information
11.5.2 Colorado Serum Overview
11.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Colorado Serum Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Colorado Serum Recent Developments
11.6 PharmAthene
11.6.1 PharmAthene Company Information
11.6.2 PharmAthene Overview
11.6.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 PharmAthene Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 PharmAthene Recent Developments
11.7 Tiankang
11.7.1 Tiankang Company Information
11.7.2 Tiankang Overview
11.7.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Tiankang Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Tiankang Recent Developments
11.8 Biogénesis-Bago
11.8.1 Biogénesis-Bago Company Information
11.8.2 Biogénesis-Bago Overview
11.8.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Biogénesis-Bago Recent Developments
11.9 CAVAC
11.9.1 CAVAC Company Information
11.9.2 CAVAC Overview
11.9.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 CAVAC Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 CAVAC Recent Developments
11.10 Rosenbusch
11.10.1 Rosenbusch Company Information
11.10.2 Rosenbusch Overview
11.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Rosenbusch Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Rosenbusch Recent Developments
11.11 Agrovet
11.11.1 Agrovet Company Information
11.11.2 Agrovet Overview
11.11.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Agrovet Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Agrovet Recent Developments
11.12 Vecol
11.12.1 Vecol Company Information
11.12.2 Vecol Overview
11.12.3 Vecol Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Vecol Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Vecol Recent Developments
11.13 CVCRI
11.13.1 CVCRI Company Information
11.13.2 CVCRI Overview
11.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 CVCRI Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 CVCRI Recent Developments
11.14 IVPM
11.14.1 IVPM Company Information
11.14.2 IVPM Overview
11.14.3 IVPM Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 IVPM Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 IVPM Recent Developments
11.15 Prondil
11.15.1 Prondil Company Information
11.15.2 Prondil Overview
11.15.3 Prondil Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Prondil Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Prondil Recent Developments
11.16 CDV
11.16.1 CDV Company Information
11.16.2 CDV Overview
11.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.16.4 CDV Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 CDV Recent Developments
11.17 Indian Immunologicals
11.17.1 Indian Immunologicals Company Information
11.17.2 Indian Immunologicals Overview
11.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.17.4 Indian Immunologicals Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 Indian Immunologicals Recent Developments
11.18 Botswana Vaccine Institute
11.18.1 Botswana Vaccine Institute Company Information
11.18.2 Botswana Vaccine Institute Overview
11.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.18.4 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.18.5 Botswana Vaccine Institute Recent Developments
11.19 Ceva Santé Animale
11.19.1 Ceva Santé Animale Company Information
11.19.2 Ceva Santé Animale Overview
11.19.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.19.4 Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.19.5 Ceva Santé Animale Recent Developments
11.20 Intervac
11.20.1 Intervac Company Information
11.20.2 Intervac Overview
11.20.3 Intervac Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.20.4 Intervac Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.20.5 Intervac Recent Developments
11.21 JOVAC
11.21.1 JOVAC Company Information
11.21.2 JOVAC Overview
11.21.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Price, Revenue and Gross Margin (2018-2024)
11.21.4 JOVAC Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
11.21.5 JOVAC Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Biothrax (Anthrax Vaccine) Industry Chain Analysis
12.2 Biothrax (Anthrax Vaccine) Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Biothrax (Anthrax Vaccine) Production Mode & Process
12.4 Biothrax (Anthrax Vaccine) Sales and Marketing
12.4.1 Biothrax (Anthrax Vaccine) Sales Channels
12.4.2 Biothrax (Anthrax Vaccine) Distributors
12.5 Biothrax (Anthrax Vaccine) Customers
13 Market Dynamics
13.1 Biothrax (Anthrax Vaccine) Industry Trends
13.2 Biothrax (Anthrax Vaccine) Market Drivers
13.3 Biothrax (Anthrax Vaccine) Market Challenges
13.4 Biothrax (Anthrax Vaccine) Market Restraints
14 Key Findings in The Global Biothrax (Anthrax Vaccine) Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Figure
List of Tables
Table 1. Global Biothrax (Anthrax Vaccine) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Live Vaccines
Table 3. Major Manufacturers of Cell Free PA Vaccines
Table 4. Global Biothrax (Anthrax Vaccine) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Biothrax (Anthrax Vaccine) Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Biothrax (Anthrax Vaccine) Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Biothrax (Anthrax Vaccine) Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2018-2024)
Table 9. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2024-2029)
Table 10. Global Biothrax (Anthrax Vaccine) Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Biothrax (Anthrax Vaccine) Sales by Region (2018-2024) & (K Units)
Table 12. Global Biothrax (Anthrax Vaccine) Sales by Region (2024-2029) & (K Units)
Table 13. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2018-2024)
Table 14. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2024-2029)
Table 15. Global Biothrax (Anthrax Vaccine) Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Biothrax (Anthrax Vaccine) Sales Share by Manufacturers (2018-2024)
Table 17. Global Biothrax (Anthrax Vaccine) Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Biothrax (Anthrax Vaccine), Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Biothrax (Anthrax Vaccine) Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Biothrax (Anthrax Vaccine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Biothrax (Anthrax Vaccine) by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biothrax (Anthrax Vaccine) as of 2022)
Table 23. Global Key Manufacturers of Biothrax (Anthrax Vaccine), Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Biothrax (Anthrax Vaccine), Product Offered and Application
Table 25. Global Key Manufacturers of Biothrax (Anthrax Vaccine), Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Biothrax (Anthrax Vaccine) Sales by Type (2018-2024) & (K Units)
Table 28. Global Biothrax (Anthrax Vaccine) Sales by Type (2024-2029) & (K Units)
Table 29. Global Biothrax (Anthrax Vaccine) Sales Share by Type (2018-2024)
Table 30. Global Biothrax (Anthrax Vaccine) Sales Share by Type (2024-2029)
Table 31. Global Biothrax (Anthrax Vaccine) Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Biothrax (Anthrax Vaccine) Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Biothrax (Anthrax Vaccine) Revenue Share by Type (2018-2024)
Table 34. Global Biothrax (Anthrax Vaccine) Revenue Share by Type (2024-2029)
Table 35. Biothrax (Anthrax Vaccine) Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Biothrax (Anthrax Vaccine) Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Biothrax (Anthrax Vaccine) Sales by Application (2018-2024) & (K Units)
Table 38. Global Biothrax (Anthrax Vaccine) Sales by Application (2024-2029) & (K Units)
Table 39. Global Biothrax (Anthrax Vaccine) Sales Share by Application (2018-2024)
Table 40. Global Biothrax (Anthrax Vaccine) Sales Share by Application (2024-2029)
Table 41. Global Biothrax (Anthrax Vaccine) Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Biothrax (Anthrax Vaccine) Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Biothrax (Anthrax Vaccine) Revenue Share by Application (2018-2024)
Table 44. Global Biothrax (Anthrax Vaccine) Revenue Share by Application (2024-2029)
Table 45. Biothrax (Anthrax Vaccine) Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Biothrax (Anthrax Vaccine) Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Biothrax (Anthrax Vaccine) Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Biothrax (Anthrax Vaccine) Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Biothrax (Anthrax Vaccine) Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Biothrax (Anthrax Vaccine) Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Biothrax (Anthrax Vaccine) Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Biothrax (Anthrax Vaccine) Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Biothrax (Anthrax Vaccine) Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Biothrax (Anthrax Vaccine) Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Biothrax (Anthrax Vaccine) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Biothrax (Anthrax Vaccine) Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Biothrax (Anthrax Vaccine) Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Biothrax (Anthrax Vaccine) Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Biothrax (Anthrax Vaccine) Sales by Country (2024-2029) & (K Units)
Table 60. Europe Biothrax (Anthrax Vaccine) Sales by Type (2018-2024) & (K Units)
Table 61. Europe Biothrax (Anthrax Vaccine) Sales by Type (2024-2029) & (K Units)
Table 62. Europe Biothrax (Anthrax Vaccine) Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Biothrax (Anthrax Vaccine) Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Biothrax (Anthrax Vaccine) Sales by Application (2018-2024) & (K Units)
Table 65. Europe Biothrax (Anthrax Vaccine) Sales by Application (2024-2029) & (K Units)
Table 66. Europe Biothrax (Anthrax Vaccine) Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Biothrax (Anthrax Vaccine) Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Biothrax (Anthrax Vaccine) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Biothrax (Anthrax Vaccine) Sales by Country (2018-2024) & (K Units)
Table 72. Europe Biothrax (Anthrax Vaccine) Sales by Country (2024-2029) & (K Units)
Table 73. China Biothrax (Anthrax Vaccine) Sales by Type (2018-2024) & (K Units)
Table 74. China Biothrax (Anthrax Vaccine) Sales by Type (2024-2029) & (K Units)
Table 75. China Biothrax (Anthrax Vaccine) Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Biothrax (Anthrax Vaccine) Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Biothrax (Anthrax Vaccine) Sales by Application (2018-2024) & (K Units)
Table 78. China Biothrax (Anthrax Vaccine) Sales by Application (2024-2029) & (K Units)
Table 79. China Biothrax (Anthrax Vaccine) Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Biothrax (Anthrax Vaccine) Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Biothrax (Anthrax Vaccine) Sales by Type (2018-2024) & (K Units)
Table 82. Asia Biothrax (Anthrax Vaccine) Sales by Type (2024-2029) & (K Units)
Table 83. Asia Biothrax (Anthrax Vaccine) Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Biothrax (Anthrax Vaccine) Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Biothrax (Anthrax Vaccine) Sales by Application (2018-2024) & (K Units)
Table 86. Asia Biothrax (Anthrax Vaccine) Sales by Application (2024-2029) & (K Units)
Table 87. Asia Biothrax (Anthrax Vaccine) Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Biothrax (Anthrax Vaccine) Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Biothrax (Anthrax Vaccine) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Biothrax (Anthrax Vaccine) Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Biothrax (Anthrax Vaccine) Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Biothrax (Anthrax Vaccine) Sales by Region (2018-2024) & (K Units)
Table 93. Asia Biothrax (Anthrax Vaccine) Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales by Country (2024-2029) & (K Units)
Table 107. Merial Company Information
Table 108. Merial Description and Major Businesses
Table 109. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Merial Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Merial Recent Developments
Table 112. Merck Company Information
Table 113. Merck Description and Major Businesses
Table 114. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Merck Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Merck Recent Developments
Table 117. Zoetis Company Information
Table 118. Zoetis Description and Major Businesses
Table 119. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Zoetis Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Zoetis Recent Developments
Table 122. Bayer Sanidad Animal Company Information
Table 123. Bayer Sanidad Animal Description and Major Businesses
Table 124. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Bayer Sanidad Animal Recent Developments
Table 127. Colorado Serum Company Information
Table 128. Colorado Serum Description and Major Businesses
Table 129. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Colorado Serum Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Colorado Serum Recent Developments
Table 132. PharmAthene Company Information
Table 133. PharmAthene Description and Major Businesses
Table 134. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. PharmAthene Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. PharmAthene Recent Developments
Table 137. Tiankang Company Information
Table 138. Tiankang Description and Major Businesses
Table 139. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Tiankang Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Tiankang Recent Developments
Table 142. Biogénesis-Bago Company Information
Table 143. Biogénesis-Bago Description and Major Businesses
Table 144. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Biogénesis-Bago Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Biogénesis-Bago Recent Developments
Table 147. CAVAC Company Information
Table 148. CAVAC Description and Major Businesses
Table 149. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. CAVAC Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. CAVAC Recent Developments
Table 152. Rosenbusch Company Information
Table 153. Rosenbusch Description and Major Businesses
Table 154. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Rosenbusch Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Rosenbusch Recent Developments
Table 157. Agrovet Company Information
Table 158. Agrovet Description and Major Businesses
Table 159. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Agrovet Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Agrovet Recent Developments
Table 162. Vecol Company Information
Table 163. Vecol Description and Major Businesses
Table 164. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Vecol Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Vecol Recent Developments
Table 167. CVCRI Company Information
Table 168. CVCRI Description and Major Businesses
Table 169. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. CVCRI Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. CVCRI Recent Developments
Table 172. IVPM Company Information
Table 173. IVPM Description and Major Businesses
Table 174. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. IVPM Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. IVPM Recent Developments
Table 177. Prondil Company Information
Table 178. Prondil Description and Major Businesses
Table 179. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Prondil Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Prondil Recent Developments
Table 182. CDV Company Information
Table 183. CDV Description and Major Businesses
Table 184. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. CDV Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 186. CDV Recent Developments
Table 187. Indian Immunologicals Company Information
Table 188. Indian Immunologicals Description and Major Businesses
Table 189. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 190. Indian Immunologicals Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 191. Indian Immunologicals Recent Developments
Table 192. Botswana Vaccine Institute Company Information
Table 193. Botswana Vaccine Institute Description and Major Businesses
Table 194. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 195. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 196. Botswana Vaccine Institute Recent Developments
Table 197. Ceva Santé Animale Company Information
Table 198. Ceva Santé Animale Description and Major Businesses
Table 199. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 200. Ceva Santé Animale Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 201. Ceva Santé Animale Recent Developments
Table 202. Intervac Company Information
Table 203. Intervac Description and Major Businesses
Table 204. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 205. Intervac Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 206. Intervac Recent Developments
Table 207. JOVAC Company Information
Table 208. JOVAC Description and Major Businesses
Table 209. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 210. JOVAC Biothrax (Anthrax Vaccine) Product Model Numbers, Pictures, Descriptions and Specifications
Table 211. JOVAC Recent Developments
Table 212. Key Raw Materials Lists
Table 213. Raw Materials Key Suppliers Lists
Table 214. Biothrax (Anthrax Vaccine) Distributors List
Table 215. Biothrax (Anthrax Vaccine) Customers List
Table 216. Biothrax (Anthrax Vaccine) Market Trends
Table 217. Biothrax (Anthrax Vaccine) Market Drivers
Table 218. Biothrax (Anthrax Vaccine) Market Challenges
Table 219. Biothrax (Anthrax Vaccine) Market Restraints
Table 220. Research Programs/Design for This Report
Table 221. Key Data Information from Secondary Sources
Table 222. Key Data Information from Primary Sources
List of Figures
Figure 1. Biothrax (Anthrax Vaccine) Product Picture
Figure 2. Global Biothrax (Anthrax Vaccine) Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Biothrax (Anthrax Vaccine) Market Share by Type in 2022 & 2029
Figure 4. Live Vaccines Product Picture
Figure 5. Cell Free PA Vaccines Product Picture
Figure 6. Global Biothrax (Anthrax Vaccine) Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Biothrax (Anthrax Vaccine) Market Share by Application in 2022 & 2029
Figure 8. Human Use
Figure 9. Animal Use
Figure 10. Biothrax (Anthrax Vaccine) Report Years Considered
Figure 11. Global Biothrax (Anthrax Vaccine) Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Biothrax (Anthrax Vaccine) Revenue 2018-2029 (US$ Million)
Figure 13. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 14. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2018-2029)
Figure 15. Global Biothrax (Anthrax Vaccine) Sales 2018-2029 ((K Units)
Figure 16. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2018-2029)
Figure 17. US & Canada Biothrax (Anthrax Vaccine) Sales YoY (2018-2029) & (K Units)
Figure 18. US & Canada Biothrax (Anthrax Vaccine) Revenue YoY (2018-2029) & (US$ Million)
Figure 19. Europe Biothrax (Anthrax Vaccine) Sales YoY (2018-2029) & (K Units)
Figure 20. Europe Biothrax (Anthrax Vaccine) Revenue YoY (2018-2029) & (US$ Million)
Figure 21. China Biothrax (Anthrax Vaccine) Sales YoY (2018-2029) & (K Units)
Figure 22. China Biothrax (Anthrax Vaccine) Revenue YoY (2018-2029) & (US$ Million)
Figure 23. Asia (excluding China) Biothrax (Anthrax Vaccine) Sales YoY (2018-2029) & (K Units)
Figure 24. Asia (excluding China) Biothrax (Anthrax Vaccine) Revenue YoY (2018-2029) & (US$ Million)
Figure 25. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales YoY (2018-2029) & (K Units)
Figure 26. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue YoY (2018-2029) & (US$ Million)
Figure 27. The Biothrax (Anthrax Vaccine) Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 28. The Top 5 and 10 Largest Manufacturers of Biothrax (Anthrax Vaccine) in the World: Market Share by Biothrax (Anthrax Vaccine) Revenue in 2022
Figure 29. Global Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2029)
Figure 31. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2018-2029)
Figure 32. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2029)
Figure 33. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2018-2029)
Figure 34. US & Canada Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2029)
Figure 35. US & Canada Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2018-2029)
Figure 36. US & Canada Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2029)
Figure 37. US & Canada Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2018-2029)
Figure 38. US & Canada Biothrax (Anthrax Vaccine) Revenue Share by Country (2018-2029)
Figure 39. US & Canada Biothrax (Anthrax Vaccine) Sales Share by Country (2018-2029)
Figure 40. U.S. Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 41. Canada Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 42. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2029)
Figure 43. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2018-2029)
Figure 44. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2029)
Figure 45. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2018-2029)
Figure 46. Europe Biothrax (Anthrax Vaccine) Revenue Share by Country (2018-2029)
Figure 47. Europe Biothrax (Anthrax Vaccine) Sales Share by Country (2018-2029)
Figure 48. Germany Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 49. France Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 50. U.K. Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 51. Italy Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 52. Russia Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 53. China Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2029)
Figure 54. China Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2018-2029)
Figure 55. China Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2029)
Figure 56. China Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2018-2029)
Figure 57. Asia Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2029)
Figure 58. Asia Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2018-2029)
Figure 59. Asia Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2029)
Figure 60. Asia Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2018-2029)
Figure 61. Asia Biothrax (Anthrax Vaccine) Revenue Share by Region (2018-2029)
Figure 62. Asia Biothrax (Anthrax Vaccine) Sales Share by Region (2018-2029)
Figure 63. Japan Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 64. South Korea Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 65. China Taiwan Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 66. Southeast Asia Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 67. India Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 68. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales Market Share by Type (2018-2029)
Figure 69. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales Market Share by Application (2018-2029)
Figure 71. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Revenue Share by Country (2018-2029)
Figure 73. Middle East, Africa and Latin America Biothrax (Anthrax Vaccine) Sales Share by Country (2018-2029)
Figure 74. Brazil Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 75. Mexico Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 76. Turkey Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 77. Israel Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 78. GCC Countries Biothrax (Anthrax Vaccine) Revenue (2018-2029) & (US$ Million)
Figure 79. Biothrax (Anthrax Vaccine) Value Chain
Figure 80. Biothrax (Anthrax Vaccine) Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices